MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Neuroprotective Effects of A Combination of Curcumin and Mucuna Prurience in Rotenone Induced Mice Model of Parkinson’s Disease

    M. Panchwadkar, P. Rane, D. Khatri, V. Undale (Pune, India)

  • Neuroprotective effects of coffee ingredients against rotenone-induced neurodegeneration in parkinsonian model

    I. Miyazaki, N. Isooka, R. Kikuoka, K. Wada, Y. Kitamura, M. Asanuma (Okayama, Japan)

  • Neuroprotective potential of curcumin in combination with piperine against 6-hydroxy dopamine induced motor deficit and neurochemical alterations in rats

    S. Singh (Moga, India)

  • Neuroprotective role of cinnamaldehyde against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease

    P. Kashyap, S. Gupta (Bihar, India)

  • Neuroprotective role of Tinospora cordifolia in MPTP induced Parkinsonian mouse model

    S. Singh, H. Birla, S. Rai, W. Zahra, S. Singh (Varanasi, India)

  • Neuropsychiatric and prognostic differences between functional and primary dystonia subtypes in a US specialized dystonia clinic: a case control study

    C. Stephen, D. Perez, N. Sharma (Boston, MA, USA)

  • Neuropsychiatric disorders in observed patients with Parkinson’s disease

    S. Lukmonov, D. Tolibov (Tashkent, Uzbekistan)

  • Neuropsychological and clinical assessment for the differential diagnosis of patients with PDD vs. DLB

    E. Fiorenzato, L. Weis, V. Camparini, F. Pistonesi, R. Schifano, E. Gasparoli, A. Antonini, R. Biundo (Venice, Italy)

  • Neuropsychological Assessment of Cognitive Dysfunction in Parkinson’s Disease: A Comparison of Four Screening Instruments

    S. Schnitzler, L. Flitsch, S. Kaesberg, J. Kessler, E. Kalbe, M. Barbe (Cologne, Germany)

  • Neuropsychological characteristics of children with tremor

    S. O'Shea, W. Garcia, E. Louis, R. Alcalay, V. Rauh (New York, NY, USA)

  • « Previous Page
  • 1
  • …
  • 107
  • 108
  • 109
  • 110
  • 111
  • …
  • 177
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • #25179 (not found)
  • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley